World's Best Scientists 2026 revealed!

D-Index & Metrics

Immunology

D-Index
62
Citations
11647
World Ranking
3165
National Ranking
269

Stephen Jolles publication distribution in Immunology in 2026

The chart shows the distribution of publications by all Research.com ranked scientists in the field of Immunology in 2026. The highlighted bar marks where Stephen Jolles sits on this spectrum.

62–71 publications: 9 scientists 72–81 publications: 23 scientists 82–91 publications: 40 scientists 92–101 publications: 72 scientists 102–111 publications: 86 scientists 112–121 publications: 108 scientists 122–131 publications: 150 scientists 132–141 publications: 160 scientists 142–151 publications: 159 scientists 152–161 publications: 189 scientists 162–171 publications: 166 scientists 172–181 publications: 181 scientists 182–191 publications: 188 scientists 192–201 publications: 187 scientists 202–211 publications: 178 scientists 212–221 publications: 158 scientists 222–231 publications: 168 scientists 232–241 publications: 159 scientists 242–251 publications: 160 scientists 252–261 publications: 148 scientists 262–271 publications: 116 scientists 272–281 publications: 125 scientists 282–291 publications: 115 scientists 292–301 publications: 111 scientists 302–311 publications: 95 scientists 312–321 publications: 97 scientists 322–331 publications: 97 scientists 332–341 publications: 99 scientists 342–351 publications: 96 scientists 352–361 publications: 68 scientists 362–371 publications: 76 scientists 372–381 publications: 71 scientists 382–391 publications: 71 scientists 392–401 publications: 62 scientists 402–411 publications: 54 scientists 412–421 publications: 41 scientists 422–431 publications: 63 scientists 432–441 publications: 53 scientists 442–451 publications: 31 scientists 452–461 publications: 42 scientists 462–471 publications: 40 scientists 472–481 publications: 29 scientists 482–491 publications: 34 scientists 492–501 publications: 30 scientists 502–511 publications: 23 scientists 512–521 publications: 41 scientists 522–531 publications: 29 scientists 532–541 publications: 28 scientists 542–551 publications: 16 scientists 552–561 publications: 18 scientists 562–571 publications: 18 scientists 572–581 publications: 17 scientists 582–591 publications: 17 scientists 592–601 publications: 17 scientists 602–611 publications: 19 scientists 612–621 publications: 13 scientists 622–631 publications: 12 scientists 632–641 publications: 11 scientists 642–651 publications: 16 scientists 652–661 publications: 9 scientists 662–671 publications: 5 scientists 672–681 publications: 13 scientists 682–691 publications: 12 scientists 692–701 publications: 6 scientists 702–711 publications: 6 scientists 712–721 publications: 9 scientists 722–731 publications: 9 scientists 732–741 publications: 6 scientists 742–751 publications: 11 scientists 752–761 publications: 10 scientists 762–771 publications: 7 scientists 772–781 publications: 12 scientists 782–791 publications: 7 scientists 792–801 publications: 5 scientists 802–806 publications: 1 scientists 807+ publications: 100 scientists
62 publications 807+

This scientist: 245 publications — 49th percentile

49% of scientists in this discipline score the same or lower.

The last bar groups every scientist with 807 publications or more.

Stephen Jolles D-index placement in Immunology in 2026

The chart shows the D-index (discipline H-index) distribution of Immunology scientists ranked by Research.com in 2026. The highlighted bar marks where Stephen Jolles sits on this spectrum.

40–41 D-Index: 28 scientists 42–43 D-Index: 91 scientists 44–45 D-Index: 157 scientists 46–47 D-Index: 192 scientists 48–49 D-Index: 175 scientists 50–51 D-Index: 188 scientists 52–53 D-Index: 177 scientists 54–55 D-Index: 155 scientists 56–57 D-Index: 194 scientists 58–59 D-Index: 201 scientists 60–61 D-Index: 197 scientists 62–63 D-Index: 201 scientists 64–65 D-Index: 173 scientists 66–67 D-Index: 167 scientists 68–69 D-Index: 172 scientists 70–71 D-Index: 199 scientists 72–73 D-Index: 184 scientists 74–75 D-Index: 133 scientists 76–77 D-Index: 162 scientists 78–79 D-Index: 127 scientists 80–81 D-Index: 121 scientists 82–83 D-Index: 125 scientists 84–85 D-Index: 121 scientists 86–87 D-Index: 102 scientists 88–89 D-Index: 96 scientists 90–91 D-Index: 75 scientists 92–93 D-Index: 72 scientists 94–95 D-Index: 74 scientists 96–97 D-Index: 66 scientists 98–99 D-Index: 68 scientists 100–101 D-Index: 49 scientists 102–103 D-Index: 60 scientists 104–105 D-Index: 54 scientists 106–107 D-Index: 36 scientists 108–109 D-Index: 23 scientists 110–111 D-Index: 52 scientists 112–113 D-Index: 41 scientists 114–115 D-Index: 34 scientists 116–117 D-Index: 25 scientists 118–119 D-Index: 28 scientists 120–121 D-Index: 11 scientists 122–123 D-Index: 20 scientists 124–125 D-Index: 27 scientists 126–127 D-Index: 19 scientists 128–129 D-Index: 20 scientists 130–131 D-Index: 16 scientists 132–133 D-Index: 17 scientists 134–135 D-Index: 14 scientists 136–137 D-Index: 15 scientists 138–139 D-Index: 9 scientists 140–141 D-Index: 11 scientists 142–143 D-Index: 9 scientists 144–145 D-Index: 9 scientists 146–147 D-Index: 7 scientists 148–149 D-Index: 7 scientists 150–151 D-Index: 7 scientists 152–153 D-Index: 5 scientists 154–155 D-Index: 8 scientists 156 D-Index: 6 scientists 157+ D-Index: 96 scientists
40 D-Index 157+

This scientist: 62 D-Index — 37th percentile

37% of scientists in this discipline score the same or lower.

The last bar groups every scientist with 157 D-Index or more.

Overview

Stephen Jolles is affiliated with the University Hospital of Wales in the United Kingdom. Their research primarily concentrates on medicine, with a substantial focus on immunology and microbiology. The scientist's work encompasses various subfields, including immunology, infectious diseases, genetics, hematology, and epidemiology.

Their research topics cover a spectrum of immunological and clinical concerns. Key areas of focus include immunodeficiency and autoimmune disorders, COVID-19 clinical research studies, SARS-CoV-2 and COVID-19 research, blood disorders and treatments, chronic lymphocytic leukemia research, platelet disorders and treatments, and the broader impacts of COVID-19 on healthcare systems.

Stephen Jolles's frequently published papers include:

  • Coronavirus disease 2019 in patients with inborn errors of immunity: An international study (2020) in the Journal of Allergy and Clinical Immunology
  • COVID-19 in patients with primary and secondary immunodeficiency: The United Kingdom experience (2020) in the Journal of Allergy and Clinical Immunology
  • COVID -19 Vaccine Response in People with Multiple Sclerosis (2021) in Annals of Neurology
  • Targeting FcRn for immunomodulation: Benefits, risks, and practical considerations (2020) in the Journal of Allergy and Clinical Immunology
  • Phase 2 multiple-dose study of an FcRn inhibitor, rozanolixizumab, in patients with primary immune thrombocytopenia (2020) in Blood Advances

Stephen Jolles has published frequently in several venues, with the highest number of publications appearing in the Journal of Clinical Immunology, followed by the Journal of Allergy and Clinical Immunology, bioRxiv (Cold Spring Harbor Laboratory), Frontiers in Immunology, and Current Opinion in Allergy and Clinical Immunology.

They collaborate regularly with other researchers, including Mark Ponsford, Andrew R. Gennery, Siobhan O. Burns, Sinisa Savic, and Emma Tallantyre.

Best Publications

  • BSACI guidelines for the management of allergic and non‐allergic rhinitis

    G. K. Scadding;S. R. Durham;R. Mirakian;N. S. Jones

  • Clinical uses of intravenous immunoglobulin

    S. Jolles;W. A. C. Sewell;S. A. Misbah

  • Coronavirus Disease 2019 in patients with inborn errors of immunity: an international study.

    Isabelle Meyts;Giorgia Bucciol;Isabella Quinti;Bénédicte Neven

  • Primary immunodeficiency diseases: Genomic approaches delineate heterogeneous Mendelian disorders.

    Asbjørg Stray-Pedersen;Hanne Sørmo Sorte;Pubudu Samarakoon;Tomasz Gambin;Tomasz Gambin

  • Whole-genome sequencing of a sporadic primary immunodeficiency cohort

    Thaventhiran Jed.;H Lango Allen;O S Burren;W Rae

  • The evolution of cellular deficiency in GATA2 mutation

    Rachel E. Dickinson;Paul Milne;Laura Jardine;Sasan Zandi

  • Loss-of-function nuclear factor κB subunit 1 (NFKB1) variants are the most common monogenic cause of common variable immunodeficiency in Europeans

    Paul Tuijnenburg;Hana Lango Allen;Hana Lango Allen;Siobhan O. Burns;Daniel Greene;Daniel Greene

  • Immunomodulatory action of intravenous immunoglobulin

    W. A. C. Sewell;S. Jolles

  • The FcRn inhibitor rozanolixizumab reduces human serum IgG concentration: A randomized phase 1 study.

    Peter Kiessling;Rocio Lledo-Garcia;Shikiko Watanabe;Grant Langdon

  • COVID-19 in patients with primary and secondary immunodeficiency: The United Kingdom experience.

    Adrian M. Shields;Siobhan O. Burns;Siobhan O. Burns;Sinisa Savic;Alex G. Richter

  • The Expanding Field of Secondary Antibody Deficiency: Causes, Diagnosis, and Management.

    Smita Y. Patel;Javier Carbone;Stephen Jolles

  • International consensus on the diagnosis and management of pediatric patients with hereditary angioedema with C1 inhibitor deficiency

    H Farkas;I Martinez-Saguer;K Bork;T Bowen

  • Mutations in TRNT1 cause congenital sideroblastic anemia with immunodeficiency, fevers, and developmental delay (SIFD)

    Pranesh K. Chakraborty;Klaus Schmitz-Abe;Erin K. Kennedy;Hapsatou Mamady

  • Disease Evolution and Response to Rapamycin in Activated Phosphoinositide 3-Kinase δ Syndrome: The European Society for Immunodeficiencies-Activated Phosphoinositide 3-Kinase δ Syndrome Registry

    Maria Elena Maccari;Hassan Abolhassani;Hassan Abolhassani;Asghar Aghamohammadi;Alessandro Aiuti

  • Current treatment options with immunoglobulin G for the individualization of care in patients with primary immunodeficiency disease.

    S. Jolles;J. S. Orange;A. Gardulf;M. R. Stein

  • British Lung Foundation/United Kingdom Primary Immunodeficiency Network Consensus Statement on the Definition, Diagnosis, and Management of Granulomatous-Lymphocytic Interstitial Lung Disease in Common Variable Immunodeficiency Disorders

    John R. Hurst;Nisha Verma;David Lowe;Helen E. Baxendale

  • Dermatological uses of high-dose intravenous immunoglobulin.

    Stephen Jolles;Jenny Hughes;Sean Whittaker

  • Hematopoietic stem cell transplantation rescues the hematological, immunological, and vascular phenotype in DADA2

    Hasan Hashem;Ashish R. Kumar;Ingo Müller;Florian Babor

  • Deficiency of Adenosine Deaminase Type 2: A Description of Phenotype and Genotype in Fifteen Cases

    Sira Nanthapisal;Claire Murphy;Ebun Omoyinmi;Ying Hong

  • Clinical applications of intravenous immunoglobulins (IVIg)--beyond immunodeficiencies and neurology.

    H.-P. Hartung;L. Mouthon;R. Ahmed;S. Jordan

  • When to initiate immunoglobulin replacement therapy (IGRT) in antibody deficiency: a practical approach

    Stephen Jolles;H. Chapel;J. Litzman

  • The variable in common variable immunodeficiency: a disease of complex phenotypes.

    Stephen Jolles

  • Current understanding and future directions

    Stephen Jolles;S. V. Kaveri;J. Orange

Frequent Co-Authors

Siobhan O. Burns
Siobhan O. Burns University College London
Andrew R. Gennery
Andrew R. Gennery Newcastle University
Jordan S. Orange
Jordan S. Orange University of Pennsylvania
Michael Borte
Michael Borte Leipzig University
Bodo Grimbacher
Bodo Grimbacher University of Freiburg
Sinisa Savic
Sinisa Savic University of Leeds
Mario Abinun
Mario Abinun Newcastle University
Mary Slatter
Mary Slatter Newcastle University
Hilary Longhurst
Hilary Longhurst Auckland District Health Board
Isabella Quinti
Isabella Quinti Sapienza University of Rome

If you think any of the details on this page are incorrect, let us know.

Report an issue

We appreciate your kind effort to assist us to improve this page, it would be helpful providing us with as much detail as possible in the text box below:

Related Online Degrees & Career Pathways

Studying Immunology in the USA opens doors to various advanced healthcare careers, particularly in nursing specialties. Many students begin their journey by exploring the best online RN programs for non nurses, which provide foundational knowledge for those transitioning into the nursing field.

For those already in nursing, an accelerated FNP program offers a fast track to becoming a Family Nurse Practitioner, a role that frequently intersects with immunological knowledge to manage patient care effectively.

Experienced FNPs considering specialization can benefit from learning how to make a smooth FNP to acute care NP transition, shifting focus toward acute and critical care environments where immunology expertise is crucial.

Understanding the financial prospects is also vital. Exploring the highest paid DNP specialties can help guide career decisions, ensuring alignment between passion for immunology and rewarding opportunities.

Best Scientists Citing Stephen Jolles

Trending Scientists